TY - JOUR
T1 - Intra-articular therapies
T2 - patient preferences and professional practices in European countries
AU - de la Torre-Aboki, Jenny
AU - Uson, Jacqueline
AU - Pitsillidou, Irene
AU - Vardanyan, Valentina
AU - Nikiphorou, Elena
AU - Rodriguez-Garcia, Sebastian C.
AU - Castellanos-Moreira, Raul
AU - Pandit, Hemant
AU - O'Neill, Terence W.
AU - Doherty, Michael
AU - Boesen, Mikael
AU - Moller, Ingrid
AU - Terslev, Lene
AU - D'Agostino, Maria Antonietta
AU - Kampen, Willm Uwe
AU - Berenbaum, Francis
AU - Naredo, Esperanza
AU - Carmona, Loreto
PY - 2022/5
Y1 - 2022/5
N2 - To assess patient perspective and professional practice of intraarticular therapies (IATs) across Europe, an expert international multidisciplinary panel designed two open web-based surveys: one targeting people who had experienced at least two IATs (44 items); and one targeting health care providers (HCPs) (160 items). Surveys were disseminated via patient and professional associations and social media. A descriptive analysis was performed. The surveys were answered by 200 patients and 186 HCPs from 26 countries, showing that IAT is routinely performed by rheumatologists (97%) and orthopaedic surgeons (89%), with specific training being compulsory in a few countries. The most frequent indications for IAT are arthritis (76%), osteoarthritis (74%), crystal arthritis (71%) and bursitis (70%); the most frequently injected joints are knee (78%) and shoulder (70%); and the most used compounds are glucocorticoids. The majority of HCPs report informing patients about side-effects (73%), benefits (72%), and the nature of the procedure (72%), which coincides with 27% of patients reporting that they had not been informed about benefits or potential complications of IATs; 73% of patients had not been asked whether they wanted an anaesthetic. Few HCPs (10%) obtain written consent (56% get oral consent, being mandatory for 32%), a procedure deemed necessary by 41% of the patients. 50% of patients reported a clear benefit of IAT and 20% experienced complications including pain, impaired mobility, rashes, or swelling. In summary, the practice of IAT is variable across Europe, and although patients perceive it as relatively safe and usually effective procedure, some gaps were identified.
AB - To assess patient perspective and professional practice of intraarticular therapies (IATs) across Europe, an expert international multidisciplinary panel designed two open web-based surveys: one targeting people who had experienced at least two IATs (44 items); and one targeting health care providers (HCPs) (160 items). Surveys were disseminated via patient and professional associations and social media. A descriptive analysis was performed. The surveys were answered by 200 patients and 186 HCPs from 26 countries, showing that IAT is routinely performed by rheumatologists (97%) and orthopaedic surgeons (89%), with specific training being compulsory in a few countries. The most frequent indications for IAT are arthritis (76%), osteoarthritis (74%), crystal arthritis (71%) and bursitis (70%); the most frequently injected joints are knee (78%) and shoulder (70%); and the most used compounds are glucocorticoids. The majority of HCPs report informing patients about side-effects (73%), benefits (72%), and the nature of the procedure (72%), which coincides with 27% of patients reporting that they had not been informed about benefits or potential complications of IATs; 73% of patients had not been asked whether they wanted an anaesthetic. Few HCPs (10%) obtain written consent (56% get oral consent, being mandatory for 32%), a procedure deemed necessary by 41% of the patients. 50% of patients reported a clear benefit of IAT and 20% experienced complications including pain, impaired mobility, rashes, or swelling. In summary, the practice of IAT is variable across Europe, and although patients perceive it as relatively safe and usually effective procedure, some gaps were identified.
KW - Intraarticular therapies
KW - Glucocorticoids
KW - Infiltrations
KW - Clinical practice
KW - Patient's experience
KW - Surveys
KW - SOFT-TISSUE INJECTIONS
KW - JOINT
KW - RHEUMATOLOGY
KW - EFFICACY
KW - KNEE
U2 - 10.1007/s00296-021-05045-5
DO - 10.1007/s00296-021-05045-5
M3 - Journal article
C2 - 34761277
VL - 42
SP - 869
EP - 878
JO - Rheumatology International
JF - Rheumatology International
SN - 0172-8172
IS - 5
ER -